INDV FY 2024 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+8.7% YoY

Gross Profit

$957M80.6% margin

Operating Income

$32M2.7% margin

Net Income

$2M0.2% margin

EPS (Diluted)

$0.01

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$7M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.7B

Stockholders' Equity

-$348M

Cash & Equivalents

$319M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+8.7%
Gross Profit	$957M	$919M	+4.1%
Operating Income	$32M	-$156M	+120.5%
Net Income	$2M	-$129M	+101.6%